Profiel
Harald Haubitz worked as the Chief Operating Officer & Member-Management Board at Cimex AG from 2001 to 2008.
He then worked as the Head-Packaging Solid Dosage Forms at F.
Hoffmann-La Roche Ltd.
from 1994 to 2001.
Later, he worked as the Head-Production & Supply Chain Management at Acino International AG from 2008 to 2012.
Haubitz holds a doctorate degree from Freie Universität Berlin.
Eerdere bekende functies van Harald Haubitz
| Bedrijven | Functie | Einde |
|---|---|---|
| ACINO HOLDING AG | Corporate Officer/Principal | 29-02-2012 |
| Cimex AG | Operationeel Directeur | 01-01-2008 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01-01-2001 |
Opleiding van Harald Haubitz
| Freie Universität Berlin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
| Cimex AG |
